Braunschweig, Germany

Reinhold Tacke

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhold Tacke. Retrieved from https://idiyas.com/inventor/reinhold-tacke-rdrnsw23

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reinhold Tacke: Innovator in Medicinal Chemistry

Introduction

Reinhold Tacke is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pharmaceutical compounds.

Latest Patents

Tacke holds a patent for "Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use." This invention provides valuable compounds that influence circulation and offers methods for their procurement, compositions containing these derivatives, and their applications in medicine. He has 1 patent to his name, showcasing his expertise in developing medicinal solutions.

Career Highlights

Reinhold Tacke is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative research and development in the field of medicinal chemistry.

Collaborations

Throughout his career, Tacke has collaborated with talented professionals, including Anke Bentlage and Robertson Towart. These collaborations have contributed to the advancement of his research and the successful development of new medicinal compounds.

Conclusion

Reinhold Tacke's contributions to medicinal chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…